Jones Financial Companies
XFOR icon

Jones Financial Companies’s X4 Pharmaceuticals XFOR Stock Holding History

Jones Financial Companies’s Portfolio XFOR Stock Details XFOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$153 Hold
38
– – ﹤0.01% 4866
2026
Q1 		$154 Hold
38
– – ﹤0.01% 4614
2025
Q4 		$152 Hold
38
– – ﹤0.01% 4289
2025
Q3 		$131 Hold
38
– – ﹤0.01% 4148
2025
Q2 		$70 Hold
38
– – ﹤0.01% 3961
2025
Q1 		$286 Buy
+38
New +$523 ﹤0.01% 3566

Other funds holding XFOR

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
SVCM
Saturn V Capital Management Austin, Texas $697M AUM 628.57% 1-Year Est. Return
EAM
Empery Asset Management New York $86.5M AUM
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $174M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Jones Financial Companies's XFOR Position: Q2 2026 in Review

Jones Financial Companies held its X4 Pharmaceuticals (XFOR) position steady in Q2 2026 at 38 shares worth $153. The position accounts for ﹤0.01% of the portfolio, ranked #4866.

Jones Financial Companies first reported a position in XFOR in Q1 2025 and has held it in 6 quarters since. The position peaked at $286 in Q1 2025. 89 funds tracked by Wall St. Rank hold XFOR as of Q2 2026.

  • Jones Financial Companies held 38 shares of X4 Pharmaceuticals worth $153 as of Q2 2026.
  • Jones Financial Companies left its X4 Pharmaceuticals share count unchanged in Q2 2026.
  • X4 Pharmaceuticals made up ﹤0.01% of Jones Financial Companies's portfolio in Q2 2026, its #4866 holding.
  • Jones Financial Companies first reported a position in X4 Pharmaceuticals in Q1 2025 and has held it in 6 quarters since.
  • Jones Financial Companies's X4 Pharmaceuticals position peaked at $286 in Q1 2025.
  • 89 funds tracked by Wall St. Rank held X4 Pharmaceuticals as of Q2 2026.

Based on Jones Financial Companies's 13F filing for Q2 2026, filed 14 Aug 2026.